NNL-10

N/A

Report date: 2025/01/26 16:02:27

Base Information

Drug NameNNL-10
Drug Alias Nameprotein nanoparticle conjugated auristatin (Nanoligent)NNL-10
ClassificationBiologics
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsLeukemia, Myeloid, AcuteNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversitat Autonoma De Barcelona
China Registration ClassN/A

Develop Information

Active CompaniesNanoligent SL
Inactive CompaniesInstitut de Recerca de l'Hospital de la Santa Creu i Sant PauUniversitat Autonoma De BarcelonaConsorcio Centro de Investigación Biomédica en Red (CIBER)
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A